STAGE IVB OSTEOSARCOMA AJCC V7
Clinical trials for STAGE IVB OSTEOSARCOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVB OSTEOSARCOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IVB OSTEOSARCOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug shows promise for rare bone cancers
Disease control OngoingThis study tests a drug called cabozantinib in people whose osteosarcoma or Ewing sarcoma has returned or worsened after standard treatment. The drug works by blocking enzymes that help cancer cells grow and by cutting off the blood supply tumors need. The main goal is to see if …
Matched conditions: STAGE IVB OSTEOSARCOMA AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 06:17 UTC
-
Gene test trial aims to personalize cancer care for kids
Knowledge-focused OngoingThis study screens children and young adults (ages 1-21) with advanced solid tumors, lymphomas, or related disorders that have not responded to standard therapy. Researchers analyze the genetic makeup of each patient's tumor to find specific mutations that can be targeted by cert…
Matched conditions: STAGE IVB OSTEOSARCOMA AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 17, 2026 06:14 UTC